It has been proved that low levels of FBXO6 and consequent impairment of replication stress-induced Chk1 degradation are associated with resistance to camptothecin of BC [13], the similar results about drug-resistance have been confirmed in small cell lung cancer by Cai et al. [41]. This evidence concerns the gene CHEK1 and breast cancer.